News
Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...
The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform Foundation® (GAP) applauds the FDA's clearance ...
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results